Original Research
Published on 04 Jun 2021
Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer
in Breast Cancer
Frontiers in Oncology
doi 10.3389/fonc.2021.689587
- 10,685 views
- 20 citations
